ENERGI-F703

· Energenesis Biomedical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ENERGI-F703, covering 2020-11-24 to 2020-11-24. Get the full timeline:

Most recent: Clinical Trial Update: ENERGI-F703 for Diabetic Foot Ulcers Phase II Study [Phase 2]